Status:
COMPLETED
Oral/Intramuscular B12 to Treat Cobalamin Deficiency
Lead Sponsor:
Gerencia de Atención Primaria, Madrid
Collaborating Sponsors:
Instituto de Salud Carlos III
Conditions:
Vitamin B 12 Deficiency
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Objective: To determine the effectiveness of oral versus intramuscular Cobalamin (vitamin B12) by restore cobalamin parameter in blood at 8, 26 and 52 weeks in ≥ 65 aged patients with Cobalamin Defici...
Detailed Description
Variables. Main outcome variable: Cobalamin level standardization (yes/no). Secondary outcome variables: Adverse events. Adherence measurement of treatment. Health related quality of life questionnair...
Eligibility Criteria
Inclusion
- ≥ 65 aged patients with Cobalamin Deficiency.
- Patients give inform consent.
Exclusion
- Treatment with B12 (1 last year)
- Neurologic or psychiatric pathologies
- Folic acid \< 2.3ng/ml ...
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2017
Estimated Enrollment :
284 Patients enrolled
Trial Details
Trial ID
NCT01476007
Start Date
July 1 2014
End Date
November 28 2017
Last Update
November 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gerencia Atención Primaria, Madrid
Madrid, Spain, 28035